FDA Inspection 1083841 — Noramco, Inc.
The FDA completed an inspection of Noramco, Inc. on Feb 21, 2019 in Wilmington, DE. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 21, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Wilmington, DE (United States)